Company Moves Against Stock "Bashers"

TAMPA BAY, FL, Dec. 4 /PRNewswire-FirstCall/ - Hard to Treat Diseases, Inc. (HTDS) www.htdsmedical.com announced today that their attorney, Bradley E. Essman, has filed criminal complaints with the Federal Bureau of Investigation (FBI) and with the State police against certain anonymous stock chat site posters. The complaints call for the investigation of certain death threats made against HTDS employees, agents and representatives, including the posting of a malicious Internet link that destroyed computer memories.

Federal law makes it illegal to threaten people on the Internet and to engage in "cyber stalking." Planting malicious code on the Internet is also outlawed. Both are offenses under relevant state law.

Mr. Essman is an international business attorney and former Assistant State Attorney of Hillsborough County (Tampa), Florida, where he served with the Special Prosecutions Unit for Economic and White Collar Crimes. He has offices in Tarpon Springs and St. Petersburg, Florida.

Attorney Essman said, "We are moving every day to do more and more to bring to justice those malicious cowards who use the anonymity of Internet to harass productive people. We must stop this or else the work of many innocent people will be harmed. We intend to bring to justice all of these perpetrators. I say to these criminals, you may be surprised to find that you will soon be caught and punished."

To receive future updates via email, including quarterly newsletters and company updates that may not be newsworthy, however important to the reader and followers of the company, please sign up today for free at www.minamargroup.com/updates.

Safe Harbor Statement

Information in this news release may contain statements about future expectations, plans, prospects or performance of Hard to Treat Diseases Inc. that constitute forward-looking statements for purposes of the Safe Harbor Provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be", "expects", "may affect", "believed", "estimate", "project" and similar words and phrases are intended to identify such forward-looking statements. Hard to Treat Diseases Inc. cautions you that any forward-looking information provided by or on behalf of Hard to Treat Diseases Inc. is not a guarantee of future performance. None of the information in this press release constitutes or is intended as an offer to sell securities or investment advice of any kind. Hard to Treat Diseases Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Hard to Treat Diseases Inc.'s control. In addition to those discussed in Hard to Treat Diseases Inc.'s press releases, public filings, and statements by Hard to Treat Diseases Inc.'s management, including, but not limited to, Hard to Treat Diseases Inc.'s estimate of the sufficiency of its existing capital resources, Hard to Treat Diseases Inc.'s ability to raise additional capital to fund future operations, Hard to Treat Diseases Inc.'s ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities, and in identifying contracts which match Hard to Treat Diseases Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Hard to Treat Diseases Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

CONTACT: For any investor relations matters, please contact www.minamargroup.net/helpdesk; Investor Relations Department Inquiry, www.minamargroup.net (IR); For (M&A) and Corporate Matters, www.minamargroup.com

SOURCE Hard to Treat Diseases